Amedisys Inc
(STU:ADY)
€
86.5
0 (0%)
Market Cap: 2.90 Bil
Enterprise Value: 3.24 Bil
PE Ratio: 0
PB Ratio: 2.87
GF Score: 85/100 Amedisys Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021 / 05:20PM GMT
Release Date Price:
€202
(-0.98%)
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
Good afternoon. This is Frank Morgan. And we'll continue our afternoon series of fireside chats with the management team from Amedisys. We have Paul Kusserow, CEO; Scott Ginn, CFO; Chris Gerard; and Nick Muscato. Welcome, gentlemen.
Paul Berthold Kusserow
Amedisys, Inc. - Chairman & CEO
Hi, Frank. How are you doing?
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
We're all good. All is good. Hopefully, by next year, we'll do this thing live, and the virtual world will be a thing of the past.
Questions & Answers
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
But in the meantime, I guess we should go ahead and get started. Maybe, at a high level, could we first spend a couple of minutes just assessing
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot